Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

CEO Bernd Montag said the company is well positioned for a “U.S. versus China situation” that could arise when Donald Trump ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

Patient advocates are hoping for change under new director Michelle Tarver, while industry groups look to build on former ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

Study author Philippe Genereux said the trial data “shatter 60 years of ingrained belief on the treatment for severe aortic ...

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.

Analysts said the findings complicate the outlook for a U.S. launch of Boston Scientific's aortic valve replacement device.

The filing follows Exactech’s failure to settle product liability claims from about 2,600 patients in response to recalls of ...